Boston Scientific Corp. | Income Statement
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
7,143
7,308
7,399
8,386
9,048
9,823
Cost of Goods Sold (COGS) incl. D&A
2,608
2,720
2,835
3,043
3,177
3,346
Gross Income
4,535
4,588
4,564
5,343
5,871
6,477
SG&A Expense
3,512
3,695
3,723
4,003
4,278
4,670
EBIT
871
-
790
1,236
1,525
1,737
Unusual Expense
800
1,211
1,327
942
329
171
Non Operating Income/Expense
45
69
123
112
38
122
Interest Expense
255
217
241
234
230
269
Pretax Income
223
509
650
177
933
1,422
Income Tax
102
390
411
170
829
249
Consolidated Net Income
121
119
239
347
104
1,671
Net Income
121
119
239
347
104
1,671
Net Income After Extraordinaries
121
119
239
347
104
1,671
Net Income Available to Common
121
119
239
347
104
1,671
EPS (Basic)
0.09
0.09
0.18
0.25
0.07
1.19
Basic Shares Outstanding
1,341
1,324
1,341
1,358
1,370
1,381
EPS (Diluted)
0.09
0.09
0.18
0.25
0.07
1.19
Diluted Shares Outstanding
1,341
1,324
1,341
1,377
1,393
1,401
EBITDA
1,560
1,570
1,559
2,051
2,369
2,631
Other Operating Expense
152
48
51
104
68
70
Non-Operating Interest Income
6
5
5
5
5
3
About Boston Scientific
View Profile
